Transition Therapeutics赞助的临床试验
总计6502个结果
-
Ohio State UniversityAmerican Academy of Optometry; Transitions; Ohio Lions Eye Research Foundation; College of Optometrists... 和其他合作者完全的
-
Gut-Brain-Axis Therapeutics Inc.Pitt Hopkins Research Foundation招聘中
-
Hansoh BioMedical R&D CompanyHorizon Therapeutics Ireland DAC尚未招聘
-
Repurposed Therapeutics, Inc.National Aeronautics and Space Administration (NASA)招聘中
-
Shanghai East HospitalShanghai Juvensis Therapeutics Biotechnology Company Limited招聘中
-
Changhai HospitalShanghai Ultra-T Immune Therapeutics Co. LTD尚未招聘
-
Georgetown UniversityMerck Sharp & Dohme LLC; BioXcel Therapeutics Inc招聘中
-
Luminary TherapeuticsThe Cleveland Clinic; Case Western Reserve University招聘中
-
Neurokine TherapeuticsColumbia University; National Institute on Aging (NIA)尚未招聘
-
Shanghai Juncell TherapeuticsSecond Affiliated Hospital of Soochow University招聘中
-
Rapa Therapeutics LLCMassachusetts General Hospital; Hackensack Meridian Health尚未招聘
-
Stemirna TherapeuticsThe First Affiliated Hospital of Zhengzhou University招聘中
-
University of Texas Southwestern Medical CenterKaryopharm Therapeutics Inc终止
-
Medeor Therapeutics, Inc.California Institute for Regenerative Medicine (CIRM)完全的
-
InterveXion Therapeutics, LLCNational Institute on Drug Abuse (NIDA)终止
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, Inc完全的
-
Rapa Therapeutics LLCMassachusetts General Hospital; Hackensack Meridian Health可用的
-
Massachusetts General HospitalBristol-Myers Squibb; Leap Therapeutics, Inc.终止
-
Forma Therapeutics, Inc.Medpace, Inc.完全的
-
iTeos Belgium SABristol-Myers Squibb; GlaxoSmithKline; iTeos Therapeutics终止
-
Washington University School of MedicineCOVID -19 Therapeutics Accelerator完全的
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.主动,不招人
-
Enlivex Therapeutics Ltd.Cato Research; Accelsiors CRO & Consultancy Services主动,不招人败血症 | 腹腔内感染 | 胆囊炎,急性 | 尿路感染 | 社区获得性肺炎 | 急性胆管炎荷兰, 以色列, 法国, 比利时, 西班牙
-
Brainstorm-Cell TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)完全的
-
Taiwan Bio Therapeutics Co., Ltd.A2 Healthcare Taiwan Corporation主动,不招人
-
Craig L Slingluff, JrCelldex Therapeutics完全的
-
Juno Therapeutics, a Subsidiary of CelgeneBristol-Myers Squibb完全的肿瘤 | 组织学类型的肿瘤 | 淋巴瘤 | 淋巴瘤,B细胞 | 淋巴瘤,大 B 细胞,弥漫性 | 淋巴增生性疾病 | 淋巴系统疾病 | 免疫增生性疾病 | 淋巴瘤,非霍奇金 | 免疫系统紊乱美国
-
InterveXion Therapeutics, LLCNational Institute on Drug Abuse (NIDA)终止
-
Allyx TherapeuticsMichael J. Fox Foundation for Parkinson's Research主动,不招人
-
Craig L Slingluff, JrCelldex Therapeutics主动,不招人
-
Oui Therapeutics, Inc.National Institute of Mental Health (NIMH)邀请报名
-
SiteOne Therapeutics, Inc.National Institute on Drug Abuse (NIDA)终止
-
InterveXion Therapeutics, LLCNational Institute on Drug Abuse (NIDA)完全的
-
Cellphire Therapeutics, Inc.Department of Health and Human Services完全的
-
Olatec Therapeutics LLCCTI Clinical Trial and Consulting Services终止
-
Nektar TherapeuticsMerck Sharp & Dohme LLC; SFJ Pharmaceuticals, Inc.终止
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsGOG Foundation完全的
-
Mads Peter Godtfeldt StemmerikEdgewise Therapeutics, Inc.完全的
-
Northwestern UniversityNational Cancer Institute (NCI); Vasgene Therapeutics, Inc主动,不招人进行性疾病 | 去势抵抗性前列腺癌 | IVB 期前列腺癌 AJCC v8 | PSA 进展 | 转移性前列腺癌 | 睾酮的去势水平 | 前列腺癌骨转移 | 对第二代雄激素受体轴靶向药物无效的去势抵抗性前列腺癌 | 软组织转移性前列腺癌 | 睾酮低于 50 ng/dL美国
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Marker Therapeutics, Inc.完全的
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Nektar Therapeutics完全的
-
Kymera Therapeutics, Inc.York Dermatology Clinic and Research Centre完全的
-
Scioderm, Inc.Food and Drug Administration (FDA); Amicus Therapeutics终止
-
Regend TherapeuticsThe First Affiliated Hospital of Soochow University未知
-
First Affiliated Hospital Xi'an Jiaotong UniversityEureka Therapeutics Inc.未知
-
Insight Therapeutics, LLCBrown University; Case Western Reserve University未知